Details for 2010708442

Up to date per 01.04.2026

Actions

Title / Product Name

Tablett formulierung von N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamid zur verwendung in der Behandlung von Mukoviszidose

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2010708442

EP Publication Number

2464337

E-Number

1086439

Language

PCT Number

US10024609

Publication Date

20.06.2012 A

09.01.2019 B1

Registration Date

09.01.2019

AT Publication Date

15.01.2019

Application Date

18.02.2010

Registration Number

Priorities

13.08.2009

PCT/US2009/000462

13.08.2009

583066

IPC

A61K 9/14 20060101AFI20180613BHEP

Maximum Duration of Protection

18.02.2030

Owner

Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

ROWE, William770 Highland Avenue Medford MA 02155US

HURTER, Patricia49 Tahanto Trail Harvard MA 01451US

YOUNG, Christopher, R.42 Francis Street Unit 1 Waltham MA 02451US

DINEHART, Kirk60 Hemlock Drive Holliston MA 01746US

VERWIJS, Marinus, Jacobus4 Carter Drive Framingham MA 01701US

OVERHOFF, Kirk47 Alder Street 25 Waltham MA 02453US

GROOTENHUIS, Peter, D. J.4801 Riding Ridge Road San Diego CA 92130US

BOTFIELD, Martyn47 Walden Terrace Concord MA 01742US

GROSSI, Alfredo102 Tern Hills Road Somerville MA 02145US

ZLOKARNIK, Gregor2754 Palomino Circle La Jolla CA 92037US

VAN GOOR, Fredrick F.832 Ormond Court San Diego CA 92109US

Information about Fees